Invion aims to boost its valuation by simplifying licensing, improving financing and increasing investor awareness, focusing on Asian cancer...
4 days ago

Australia's Invion Group is emerging as a leader in the development of next generation precision photodynamic technology (PDT),...
13 hours ago

An update from Invion ( ($AU:IVX) ) is now available. Invion Limited has released its Corporate Governance Statement for the financial year...
5 days ago

Invion secures FDA Orphan Drug Designation for INV043, a photodynamic therapy targeting anal cancer with 80% preclinical efficacy in...
2 weeks ago

The latest update is out from Invion ( ($AU:IVX) ). Invion Limited has confirmed that it received an Orphan Drug Designation from the U.S....
4 days ago

Invion (ASX:IVX) has announced that the US FDA has granted orphan drug designation to INV043 for the treatment of anal cancer.
2 weeks ago

Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases ... Invion (ASX:IVX) is a clinical-stage Australian life...
4 months ago

Invion Limited (ASX: IVX), a life-science company leading the global research and development of the Photosoft™ technology for the treatment...
2 weeks ago

The latest announcement is out from Invion ( ($AU:IVX) ). Invion Limited reported a significant financial downturn for the year ended June...
5 days ago

Invion advances light-activated cancer therapy through early trials ... Invion (ASX:IVX) is progressing its Photosoft™ drug platform, designed to...
1 month ago